Know Cancer

or
forgot password


N/A
20 Years
80 Years
Not Enrolling
Female
Uterine Cervical Neoplasms

Thank you

Trial Information


Inclusion Criteria:



- be able to give informed consent.

- female patients between 20 and 80 years of age.

- biopsy proven newly diagnosed cervical cancer clinical stage International Federation
of Gynecology and Obstetrics (FIGO) Ib and above.

- patients must be willing to undergo standard treatment such as surgery or
chemo-radiation therapy.

Exclusion Criteria:

- patients who are judged to be noncompliant to treatment or not accessible for follow
up.

- patients with contraindications to magnetic resonance imaging (MRI) scanning, such as
claustrophobia, cardiac pacemaker, metal implants in field of view, or unable to
cooperate for MRI study due to mental status.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

the amounts of metabolites in uterine cervical tissue

Outcome Time Frame:

up to 8 weeks of magnetic resonance imaging and spectroscopy exam

Safety Issue:

No

Authority:

Taiwan: Institutional Review Board

Study ID:

102-0620A3

NCT ID:

NCT01874548

Start Date:

July 2013

Completion Date:

Related Keywords:

  • Uterine Cervical Neoplasms
  • Autophagy
  • Cancer metabolism
  • Cervical cancer
  • Diffusion weighted imaging
  • Human papillomavirus
  • Magnetic resonance spectroscopy.
  • Neoplasms
  • Uterine Cervical Neoplasms

Name

Location